Gujarat : Death Toll Reaches Seven In Kheda Syrup Scam, Mumbai Supplier Arrested

Ahmedabad : Another casualty has been reported at an Ahmedabad government hospital, marking the death toll at seven in the Kheda Syrup scam in Gujarat. Additionally, Kheda police have apprehended a supplier from Mumbai linked to the accused operating a syrup factory in Nadiad.

The latest victim, 72-year-old Sankar Sodha, succumbed at the government hospital in Ahmedabad. He fell ill after consuming the ayurvedic syrup, initially receiving treatment at a Nadiad hospital before being referred to the Ahmedabad government hospital. Despite four days of treatment, he succumbed early Wednesday morning

Yogesh Sindhi, one of the five accused in the syrup scandal, has been divulging critical information during police interrogation while on remand.

Kheda police conducted a search at Yogesh Sindhi’s factory near Nadiad’s Mokumpura on Monday, seizing numerous bottles filled with the syrup and chemicals from the premises.

According to Sindhi’s statement to the police, he learned about manufacturing the syrup from an acquaintance while serving a sentence in another case. Upon release, he established a factory, building a network across central Gujarat and expanding his market. To produce the syrup, he required Ethanol, establishing a business relationship with Taufiq, a Mumbai-based supplier.

The Kheda SIT team apprehended Taufiq in Mumbai, slated to appear before the court on Thursday.

In connection to the scam, Vadodara police handed over two other key players, Nitin Kotwani and Bhavesh Saukani, to Kheda police. The trial court granted a 12-day remand for both accused on Wednesday.

Kotwani and Saukani have a criminal history associated with manufacturing similar syrups. They were previously arrested by Rajkot police in Maharashtra’s Nandurbar, leading to the sealing of their factory.

Related Posts

India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

New Delhi— The government has reported robust growth in India’s medical devices industry, with 4,108 licensed manufacturers currently operating across the country and cumulative Foreign Direct Investment (FDI) inflows touching…

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

NEW DELHI—  Abbott, the global healthcare company, today announced the launch of XIENCE Skypoint in India. This is Abbott’s most advanced generation stent within the globally trusted XIENCE™ family of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Top 30 pharma companies post 12% revenue growth in first nine months

Top 30 pharma companies post 12% revenue growth in first nine months

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

AsterDMHealthcare-QCIL Merger mirrors Overwhelming Trust in Leadership

AsterDMHealthcare-QCIL Merger mirrors Overwhelming Trust in Leadership